Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

“I’m making money to afford semagultide,” Rice, 42, who works three jobs to afford the expensive ... appetite-suppressing medications, semaglutide is the active ingredient in anti-obesity ...

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

The SELECT trial findings revealed that non-diabetic, overweight, and obese adults taking semaglutide (2.4 mg) for more than three years are at 20% less risk of stroke, heart attack, or death ...

Reduction in body weight was statistically significantly greater with oral semaglutide at week 26, with a reduction of 3.7 kg compared to 1.1 kg with placebo. From a baseline HbA1c of 8.0% ...

The race to develop even more effective obesity drugs is heating up. This week, Novo Nordisk announced that people taking its mega-dose version of semaglutide lost substantially more body weight ...

The company states: “Novo Nordisk (NVO) announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial investigating ...

who works three jobs to afford the expensive injectables, explained to her over 14,000 TikTok fans. Classified as a GLP-1, appetite-suppressing medications, semaglutide is the active ingredient in ...